Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
about
Plasma catecholamines in the acute phase of the response to myocardial infarctionEthanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistanceTreating critical illness: the importance of first doing no harmHigh concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levelsPharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in childrenNeuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestionThe effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.Effect of β2-adrenergic receptor polymorphisms on epinephrine and exercise-stimulated lipolysis in humansEffects of short-term oral salbutamol administration on exercise endurance and metabolism.Factors affecting the plasma insulin concentration shortly after accidental injury in man.Glucose metabolism in children during the first day after burn injury.Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans.Tolerance to the humoral and hemodynamic effects of caffeine in man.Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentrations and their dissipation profileElevated plasma noradrenaline in response to beta-adrenoceptor stimulation in manBeta-adrenoceptor blockade in stress due to oral surgery.Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjectsDirect muscarinic cholinergic inhibition of hepatic glucose production in humans.Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in manRole of hepatic autoregulation in defense against hypoglycemia in humans.Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epineEpinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitoninDifferential effects of defibrillation on systemic and cardiac sympathetic activity.Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.Effect of diabetes on serum potassium concentrations in acute coronary syndromes.Hormonal control of substrate cycling in humans.Oral mucosal injection of a local anesthetic solution containing epinephrine enhances muscle relaxant effects of rocuronium.Use of inotropes and vasopressor agents in critically ill patients.Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?Effects of lidocaine with epinephrine on fear related arousal among dental phobics.Plasma epinephrine levels and cardiovascular response to high administered doses of epinephrine contained in local anesthesiaThe origins of cachexia in acute and chronic inflammatory diseases.Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acidAdvances in biochemical screening for phaeochromocytoma using biogenic aminesExercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy.
P2860
Q22242052-4FF64E38-F2C1-4447-8F61-879E4BFD50A9Q24622140-4E9CA2EB-2554-4F3D-AE7F-AE89D186035FQ24813804-045F536D-C974-4329-BBC5-C7BF0B92D33BQ27310045-12727501-9E2D-4F0D-8DAD-FCE7ABF60C15Q28368129-146BB8CB-5FC3-455C-A62C-1D2B2D415135Q30580672-E2C378D8-7EFB-4DC5-AF11-AEFA392B53E5Q33821879-816DD3FA-8907-43B8-83B5-D97F59B09A4AQ33821886-8002B9BC-5405-4914-87D9-03B67EBC0A80Q33836122-0C27A554-A2D6-424E-B75C-65900324586CQ33847785-5BF524BF-8F92-4670-8565-C4B8D59A6DA7Q33902911-C15086CA-0287-46C6-A7D8-00E70530C044Q33912383-DDB380C3-CDC8-40FD-967B-887DA6664665Q34138076-22D3674B-2A20-4EF1-AEF9-08E010C53606Q34138744-A6B0C286-0C68-4C62-9D53-777C437A4575Q34248284-FC4E0290-39B4-4A0A-A050-33D40EF61EE9Q34275684-7C27A7EE-76D7-499D-BCF4-03E61659F15DQ34398494-D1E19262-817A-4E1C-9450-94377EC128D1Q34416756-3FB2A49E-89F3-45CC-8ED3-58015B8CD54BQ34450076-F337268A-9436-42AC-AE55-C2BC2F95EDC7Q34450261-27362E86-83CF-4339-A3CA-2BD0C3D4D1CAQ34519321-336A4D78-D5F4-468D-A6C1-7FB27797CC75Q34541402-9C61C823-B41C-4019-B34C-6858C51547F3Q34559150-42D7A3CA-30A3-4DD5-9E11-7A8AD04DF7E5Q34602608-C0618F48-856A-4641-99DA-E03630CD76B8Q34627940-515AD332-FECE-4DF1-BB63-A31D49F2E69DQ34629732-EDA9D7E9-B225-47F0-AF2C-32923F1AAE2CQ35204163-44EA1D6F-272E-4B75-A45D-2C73531391BAQ35367958-E716718F-2B14-4C62-AFB2-2006FD796E78Q35577195-DB723C4C-3853-455A-A288-9779DD5F1C31Q35580721-E1A5A00D-E0C0-4989-A1CC-6465B78DEEEAQ35588346-E81C3007-CD53-480A-915B-010738F5DAACQ35843524-D9C7CA3E-AE26-4A86-9CEC-4EED59304B62Q36147248-6B487631-D2AE-42CA-A7EA-C9A523E6782FQ36192991-102ACEAC-F2AB-4369-B6A6-E5B57AD11652Q36331844-00EC6053-F903-49C9-8EE7-24699FB413CEQ36344929-03655FA3-55D5-4256-AEB4-E4819284BD2FQ36378758-E28478E4-6016-44A4-9CFF-849D3FDE0D7FQ37000183-DA8CE958-0A8A-4655-9B72-DFE046F57885Q37098116-F6B943B4-93ED-457E-B237-45A50FD1DECEQ37273001-5A3A3643-228E-4C16-A7F7-118AF92D27E9
P2860
Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1980
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@en
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@nl
type
label
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@en
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@nl
prefLabel
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@en
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@nl
P2093
P2860
P356
P1476
Epinephrine plasma metabolic c ...... nd hemodynamic actions in man.
@en
P2093
P2860
P304
P356
10.1172/JCI109840
P407
P577
1980-07-01T00:00:00Z